News

The integration of targeted therapies into neuro-oncology is revolutionizing the management of primary CNS malignancies. Advances in sequencing technologies and the incorporation of molecular ...
Timely, consistent integration of palliative care services benefits pediatric patients with high-risk brain tumors.
The Brain Prize 2025 went to neuro-oncologists Michelle Monje and Frank Winkler for pioneering the field of cancer n.
The FDA has granted 501(k) clearance to ZEISS INTRABEAM 700, a robotic-assisted platform designed to enhance intraoperative ...
Prevent Cancer Foundation's 2025 Early Detection Survey showed that only about half of U.S. adults 21 years and older said ...
A Kingston neurosurgeon has helped brain tumour patients receive treatment more quickly and with better communication, thanks ...
Hassenfeld Children's Hospital, a paediatric hospital in New York, US, has joined the Children's Brain Tumor Network (CBTN) ...
With its new treatment platform for intraoperative radiotherapy, ZEISS is actively shaping the medical innovation of neuro ...
The potential for cell and gene therapies is growing, offering groundbreaking treatments for rare genetic disorders and ...
In what could be the first-of-its kind in the country, the Sher-e-Kashmir Institute of Medical Sciences (SKIMS), Soura, is ...
Imagine a Texas where Alzheimer’s disease can be treated like diabetes. A $3 billion fund making its way through the ...
Spatial biology first entered the omics scene about a decade ago. Since then, the technology has generated significant buzz ...